biguanides has been researched along with Infections, Soft Tissue in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fabry, W | 1 |
Trampenau, C | 1 |
Bettag, C | 1 |
Handschin, AE | 1 |
Lettgen, B | 1 |
Huber, FX | 1 |
Hillmeier, J | 1 |
Kock, HJ | 1 |
Wagner, M | 1 |
1 trial available for biguanides and Infections, Soft Tissue
Article | Year |
---|---|
Bacterial decontamination of surgical wounds treated with Lavasept.
Topics: Bacterial Infections; Biguanides; Colony Count, Microbial; Disinfectants; Double-Blind Method; Gram- | 2006 |
1 other study available for biguanides and Infections, Soft Tissue
Article | Year |
---|---|
[Local antisepsis in infected total hip endoprosthesis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Biguanides; Debridement; Female; Hemat | 1995 |